Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
by on Wednesday, October 26th, 2011 | No Comments
Condition: Leukemia, Pediatric
Intervention: Drug: Dasatinib
Sponsors: Bristol-Myers Squibb; Children’s Oncology Group; EsPhALL – European Intergroup Study on Post Induction Treatment of Philadelphia Positive Acute Lymphoblastic Leukaemia with Imatinib
Not yet recruiting – verified October 2011
Follow this link: Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia